Viking Therapeutics is developing VK2735, a GLP-1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock is soaring.
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
Yields on municipal bonds — adjusted for taxable-equivalent comparisons — have widened dramatically over those of corporate bonds over the past two months.
Under a revised FTC order, more Amazon users qualify for a refund and the maximum payout been raised from $51 to $200.
Analysts and investors view the stock response as reasonable for one reason.
The U.S. "will no longer permit threats to America to gain a foothold anywhere in the Western Hemisphere," Trump will say, according to his prepared remarks.
I let my spending get away from me. Here’s how I’m getting back on track.
The research firm initiated coverage of the med-tech stock with a buy rating.
The changes will cut about $1 trillion from federal Medicaid spending over 10 years.
The "September surge" might boost hiring this fall, but the Fed rate hike could slow down the job market. Here's what experts say to do.
Big investors really like stocks right now.
Rerun generation, Gen X, seems obsessed with finding parallels between today's market and past cycles, Mike Santoli writes.
Binance will invest $100 million in stablecoin issuer Circle and agreed to promote the stablecoin issuer's flagship USDC on its platform.
Futures are indicating a relatively steady open following yesterday's AI-driven stock rally.
“I draw from my IRA as needed for household repairs, trips and other larger expenses.”
It's the latest move by the company as it and other event contract exchanges seek to gain greater participation by institutional traders.
AI is everywhere, leaving investors exposed if the technology doesn’t pan out as expected.
Here are Tuesday's biggest calls on Wall Street.
These are the stocks posting the largest moves in early trading.
Widening credit spreads worldwide are a sign that how stocks are valued may be changing for the worse.